These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33252581)

  • 21. HbA1c variability as an independent predictor of diabetes retinopathy in patients with type 2 diabetes.
    Hu J; Hsu H; Yuan X; Lou K; Hsue C; Miller JD; Lu J; Lee Y; Lou Q
    J Endocrinol Invest; 2021 Jun; 44(6):1229-1236. PubMed ID: 32897535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients.
    Salti HI; Nasrallah MP; Taleb NM; Merheb M; Haddad S; El-Annan J; Khouri A; Salti IS
    Can J Ophthalmol; 2009 Jun; 44(3):308-13. PubMed ID: 19491987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Pentraxin 3 level as a recent biomarker of diabetic retinopathy in Egyptian patients with diabetes.
    Elbana KA; Salem HM; Abdel Fattah NR; Etman E
    Diabetes Metab Syndr; 2019; 13(4):2361-2364. PubMed ID: 31405644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High HbA1c level was the most important factor associated with prevalence of diabetic retinopathy in Taiwanese type II diabetic patients with a fixed duration.
    Sheu SJ; Liu NC; Ger LP; Ho WL; Lin JY; Chen SC; Horng YH; Lam HC
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2087-92. PubMed ID: 23504104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for progression of diabetic retinopathy in Alberta First Nations communities.
    Rudnisky CJ; Wong BK; Virani H; Tennant MT
    Can J Ophthalmol; 2012 Aug; 47(4):365-75. PubMed ID: 22883847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic control predicts diabetic extrarenal microvascular complications but not renal survival in patients with moderate to severe chronic kidney disease.
    Crook ED; Patel S
    Ethn Dis; 2006; 16(4):865-71. PubMed ID: 17061739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes.
    Sartore G; Chilelli NC; Burlina S; Lapolla A
    Acta Diabetol; 2013 Jun; 50(3):437-42. PubMed ID: 23417155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of serum delta-like ligand-4 level with the severity of diabetic retinopathy.
    Zhu Y; Hu J; Du X; Fang Q; Zhou Y; Chen K
    BMC Endocr Disord; 2021 Aug; 21(1):157. PubMed ID: 34362349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum uric acid concentration is associated with worsening in severity of diabetic retinopathy among type 2 diabetic patients in Taiwan--a 3-year prospective study.
    Lee JJ; Yang IH; Kuo HK; Chung MS; Chen YJ; Chen CH; Liu RT
    Diabetes Res Clin Pract; 2014 Nov; 106(2):366-72. PubMed ID: 25108898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Insights into Diabetic and Vision-Threatening Retinopathy: Importance of Plasma Long Pentraxine 3 and Taurine Levels.
    Güngel H; Erdenen F; Pasaoglu I; Sak D; Ogreden T; Kilic Muftuoglu I
    Curr Eye Res; 2021 Jun; 46(6):818-823. PubMed ID: 33044093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients.
    Laursen JV; Hoffmann SS; Green A; Nybo M; Sjølie AK; Grauslund J
    Curr Eye Res; 2013 Jan; 38(1):174-9. PubMed ID: 22906118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of basal insulin supplement therapy on diabetic retinopathy in short-duration type 2 diabetes: A one-year randomized parallel-group trial.
    Mu PW; Tang XX; Tan Y; Wang YN; Lin S; Wang MM; Shu J; Wang J; Zhang YJ; Liang H; Lin BR; Cai MY; Chen YM
    J Diabetes; 2019 Dec; 11(12):949-957. PubMed ID: 30973204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Risk Factors for Diabetic Retinopathy in a Chinese Population: A Cross-Sectional Study.
    Sun Q; Jing Y; Zhang B; Gu T; Meng R; Sun J; Zhu D; Wang Y
    J Diabetes Res; 2021; 2021():5340453. PubMed ID: 33575359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes.
    Kim HU; Park SP; Kim YK
    Sci Rep; 2021 Feb; 11(1):4731. PubMed ID: 33637847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinopathy among Chinese subjects with type 2 diabetes mellitus in Shanghai: A community-based follow-up study.
    Qin F; Jing L; Jia L; Lou J; Feng Y; Long W; Yang H; Shi R
    Int J Health Plann Manage; 2019 Jul; 34(3):998-1012. PubMed ID: 31373063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum CA 19-9 Level is Correlated to the Clinical Characteristics and Chronic Complications of Patients Newly Diagnosed with Type 2 Diabetes Mellitus.
    Cui L; Lv N; Li B; Tao J; Zheng X; Yan Y; Liu C
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):581-586. PubMed ID: 31461764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
    Ozmen B; Boyvada S
    J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy.
    Vilsbøll T; Bain SC; Leiter LA; Lingvay I; Matthews D; Simó R; Helmark IC; Wijayasinghe N; Larsen M
    Diabetes Obes Metab; 2018 Apr; 20(4):889-897. PubMed ID: 29178519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.